TICOVAC is a vaccine designed to provide protection against tick-borne encephalitis (TBE), a viral infectious disease that affects the central nervous system. TBE is transmitted to humans through the bite of infected ticks, or in some cases, through the consumption of unpasteurized dairy products from infected animals. TICOVAC works by stimulating the body's immune system to produce antibodies against the TBE virus, thereby offering immunity to those vaccinated. It is used in areas where TBE is prevalent, and is recommended for individuals who live in or travel to these regions, and are at risk of exposure to tick habitats. The vaccine is administered in a series of doses for optimal protection, with the need for booster doses depending on ongoing risk of exposure.